Testing ways to help primary care clinics diagnose familial hypercholesterolemia
Tests strategies to improve familial hypercholesterolemia diagnosis in primary care clinics, for adults.
Key facts
- Who runs it
- Geisinger Clinic
- Where
- Multiple Locations, United StatesSee the site
- Trial code
- Registry title
- Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
- Status
- Enrolling by invitation
- People taking part
- 532 people, planned
- Started
- 9 Sept 2022
- Expected to end
- Jan 2027
- Type of study
- Interventional, 5 groups
- Treatments tested
- FH diagnosis program
- Implementation strategy package: Develop and implement tools for quality monitoring
- Implementation strategy package: Develop educational materials
- Implementation strategy package: Conduct educational outreach visits
- Implementation strategy package: Intervene with clinicians and patients to enhance
- Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions
- Implementation strategy package: Audit and provide feedback
- Implementation strategy package: Stage implementation scale up
- Record updated
- 22 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for primary care clinicians (pediatrics, community medicine, internal medicine) in the Geisinger Healthcare System. It tests ways to improve diagnosis of familial hypercholesterolemia.
- Age
- 26 Years and older
- Sex
- All
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Primary care clinicians (pediatrician, community medicine, internal medicine) in the Geisinger Healthcare System
Who cannot take part
- None
Where in United States
- Geisinger ClinicMultiple Locations, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Diagnosis rates of familial hypercholesterolemia (FH) are low in the United States, despite multiple guidelines and recommendations for screening and treatment of high cholesterol, to prevent heart attacks in those affected. Using a stepped-wedge design, the investigators plan to utilize tools from implementation science to improve uptake, acceptability, and sustainability of FH diagnostic programs in primary care settings. If successful, this study will provide tools generalizable to other health care systems to improve FH diagnosis rates.
The 5 groups in the trial
- Phase 1Other group
Phased rollout to clinic sites across the the Geisinger system using stepped wedge design
Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up
- Phase 2Other group
Phased rollout to clinic sites across the the Geisinger system using stepped wedge design
Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up
- Phase 3Other group
Phased rollout to clinic sites across the the Geisinger system using stepped wedge design
Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up
- Phase 4Other group
Phased rollout to clinic sites across the the Geisinger system using stepped wedge design
Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up
- Phase 5Other group
Phased rollout to clinic sites across the the Geisinger system using stepped wedge design
Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
- Plain-language title
- Testing ways to help primary care clinics diagnose familial hypercholesterolemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.Journal of clinical lipidology, 2024
- Record updated
- 22 December 2025